With thanks to Wfarrance who posted most of the following
With thanks to Wfarrance who posted most of the following on Ihub - it is also as I remember it being presented. Whether you like the information presented or not this is a fair summary of the investor conference call. No live questions were taken.
MyECheck Investor Conference Call: June 5, 2015 Hosted by: Ed Starrs
• Can you provide 12 month revenue projection from new bank deal? I can’t disclose that now, but it will be very large… will launch in June.
• Do you have revenue projections? Similar to Q1. Revenue projection should be substantially better later in the year.
• Marketing strategy targeted at 5 market segments: Micro-business (like a local gardener), small business (through re-sellers called ISO’s and banks), big businesses, and government are being marketed directly by MYEC. (Not sure what the 5th segment is)
• Have you talked to Bill Gates? No.
• VX Gateway…not sure what is happening…not sure that relationship is viable anymore.
• SIONIC will go live in July and gas pumps will go live in August.
• Barclays is not the international bank MYEC is working with. Can’t disclose who the bank is yet.
• Ed said he will have a firm date for apps to upload to Apple and Google by early next week
• Ed should have other firm dates for other client launches very soon.
• Cardinal Commerce… the relationship is still alive. We will work with their sales team and they will be a re-seller.
• Qualix… waiting to coordinate with bank.
• MJ Pay… we will be uploading apps shortly after MYEC apps. We don’t have a contracted bank for MJ Pay app and we need one in place in order to launch. Once it is operational, it will be spun off as a whole new company with a new valuation.
• Is MYEC involved with the Avidia Bank app? Ed isn’t sure but thinks we probably are. The relationship is new and evolving. If they announce a new payment product it will likely be MYEC.
• Why did Seergate allow MYEC to acquire them. Seergate didn’t have the Africa deal before the acquisition. Seergate was somewhat “dead in the water”. MYEC was able to move the Africa deal past “first base” after acquiring.
• Ed will be in Africa in a few week right around the time of the launch.
• Ed can’t mention which countries we are working with in Africa… it is not South Africa. Bank partner will launch with 18 countries in Africa.
• P2P transfers are more susceptible to money laundering so they require transmitter licenses. The product we are launching will be a consumer to business product. The mobile commerce system will launch in three stages… first stage is: load wallet and transfer payments from bank to merchant, merchant can provide a discount to drive consumers to use the app. We will offer P2P version in the future.
• Sold license and delivering the product to Itonis within about 30 days. Itonis believes they have a bank lined up but it is a little up in the air. The app is ready when the bank is in place.
• Form 10 application was filed. We closed on Seergate and thought Seergate financials were sufficient for SEC. The SEC advised that Seergate’s financials needed to be fully compliant and we simply weren’t able to get it done in time for SEC to review before June 6. We are now getting financials audited and will re-file and expect it to sail through. SEC said everything else is in order. It is going to happen. It is a big deal for us but it isn’t the most important thing we are working on…like rolling out the mobile commerce solutions.
• No longer working with Bruce Smith and upgraded our SEC counsel.
• The fraudulent shares have either already been sold into the market (Scottsdale) or they are being held by the Government in Belize. We should get a default judgment against the fraudulent company on the Belize government “held” shares. Scottsdale filed a motion to dismiss and failed. We should win the Scottsdale lawsuit.
• We are operating at just shy of cash-flow positive and should be positive by next month.
• Volume from existing customers is not huge. We are a “development stage company” and we are focused on development of future product and less on current revenue. Product has taken longer than we expected. This doesn’t change anything other than it is taking longer. Nothing bad has happened. In fact much more positive things have happened as a result of delays. Africa and downloadable merchant point of sale are the two most exciting objectives right now.
• When will we see a dramatic turnaround with the company… latter half of June! We are doing a controlled launch in Africa to manage risk. We have integrated into the bank’s core. As we get more experience in Africa, we will apply what we learn to future roll out with U.S. banks
MyEcheck Inc (MYEC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Construction Gets a Streamlined Boost with Raken's New Tool In construction, chaos often partners seamlessly with progress. But Raken is stepping in to shake things up a bit. This isn’t just another run-of-the-mill software update; this is Raken flexing its muscles in the construction tech arena. They’ve rolled out Change Orders, enhancing their project management...
Continue Reading
The world keeps marching forward, and here’s Striveworks stepping up to the plate with another big move in the military tech space. This isn't your average partnership renewal; this involves a five-year, $200 million deal to enhance battlefield AI as the U.S. Army hones its modern warfare edge in the Indo-Pacific. Now, this isn't just a battle of strategies but a battle...
Continue Reading
So, Atlanta's Icebox Diamonds & Watches just dropped a news bomb that could shake up anyone with a taste for glitz and a wallet ready to act. This iconic jeweler, swinging its roots from a humble family biz to a global gem, is opening up its vault with an Inventory Reduction Sale starting October 9. And folks, it’s happening right at their Buckhead flagship showroom....
Continue Reading
Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...
Continue Reading
Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...
Continue Reading
AI Changes the SEO Game Rank Math, the brains behind a trusty WordPress SEO plugin, has thrown a bold prediction at us: AI visibility is set to become a standard SEO metric next year. Gurugram, India, saw this gem of an announcement on October 9, 2026. So, what's ticking here? Consumers, more than ever, are resting on AI-generated answers to make decisions. It's like...
Continue Reading
Major Win for San Francisco's Parking Professionals Parking lots and garages across San Francisco might not be the first places you’d look for labor triumphs, but that’s exactly what almost 1,000 members of Teamsters Local 665 have achieved. Under a newly ratified four-year master contract, these parking pros snagged one of the richest deals the industry has seen. A...
Continue Reading
Unpacking Neobanx's Strategic Play Straight off the tarmac, Neobanx launches Ingram Mercantile, placing their bets on the aviation sector with none other than Eli Stepp at the helm. This ain't just another day in the sky for those in the know; it's part of a gutsy bid to inject some high-octane intelligence into the world of retail. I mean, have you seen the landscape...
Continue Reading
Rethinking Liver Cancer Detection with HelioLiver Sometimes you stumble upon a tech piece that might genuinely shake up the game. Helio Genomics just poured some serious intel at the San Antonio Liver Cancer Symposium, showcasing how their HelioLiver Dx might outgun traditional scans in sniffing out hepatocellular carcinoma (HCC). They threw down four studies revealing...
Continue Reading
Avoid Turning Halloween Fun Into a Medical Emergency Halloween should be about ghosts and ghouls, not a dreaded detour to the ER. Yet, every year, adults and kids get carried away with costumes, only to find themselves in a real-life horror show courtesy of a slip, a fall, or a carving mishap. The American Academy of Orthopaedic Surgeons (AAOS) is waving the safety flag,...
Continue Reading
Top 5 Most Recently Viewed Articles
In a clear push to bolster the middle class, US Vice President Kamala Harris is shaking things up with fresh proposals that center on tax incentives aimed at reigniting union jobs. This isn’t just hot air; she’s drawing from the significant historical legacy of unionized employment, especially within the steel industry—a sector that’s been a backbone for many...
Continue Reading
Revolutionizing Investment Opportunities with ExoraPad As the cryptocurrency landscape experiences a shift towards a more optimistic outlook, seasoned XRP investors are once again eager to explore new opportunities. Among the latest trends, ExoraPad is capturing substantial interest, particularly from XRP whales who are making significant moves within the project’s...
Continue Reading
Stifel Financial Reports Key Operating Insights for May 2025 ST. LOUIS — Stifel Financial Corp. (NYSE: SF) has provided valuable insights into its operational performance for May 31, 2025. As a leading financial services holding company, Stifel aims to keep investors informed about critical performance metrics despite the preliminary nature of this data. Leadership...
Continue Reading
Warren's Criticism of Trump Family Financial Gains Sen. Elizabeth Warren (D-Mass.) has openly critiqued the financial surge experienced by the Trump family due to the World Liberty Financial (WLFI) token. She has firmly classified this incident as an example of 'corruption.' Claims of Corruption Surround WLFI Token Gains On social media platform X, Warren expressed her...
Continue Reading
Matthias Will, M.D. Joins Autolus Therapeutics Autolus Therapeutics plc, a clinical-stage biopharmaceutical company known for its development of next-generation programmed T cell therapies, has announced a significant addition to its executive team. Matthias Will, M.D., has been appointed as the Chief Development Officer. With his extensive background in the biotech...
Continue Reading